Findings

What do systematic reviews say?

2,234 questions · 2,325 findings · 216 reviews · Airways

Sort:Best matchNewestHighest certainty Download CSV

No studies found 249 · 10.7%GRADE not reported 107 · 4.6%Very low 276 · 11.9%Low 751 · 32.3%Moderate 718 · 30.9%High 224 · 9.6%

Myofunctional therapy vs respiratory exercises + nasal dilator strip

Quality of sleep · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 97 participants
Moderate

Myofunctional therapy vs respiratory exercises + nasal dilator strip

AHI · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Myofunctional therapy vs sham

Quality of sleep · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 31 participants
Low

Myofunctional therapy plus nasal washing vs Nasal washing alone

AHI score reduction to below 5 points. · obstructive sleep apnoea

Myofunctional therapy plus nasal washing showed no clear difference in AHI score reduction to below 5 points. compared with nasal washing alone (low certainty).

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
OR 12.5 [0.84, 186.3]
1 study · 13 participants
Low

Myofunctional therapy plus nasal washing vs Nasal washing alone

AHI score change. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 13 participants
Low

Myofunctional therapy vs medical treatment

Daytime sleepiness (ESS): change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Myofunctional therapy vs medical treatment

Quality of sleep · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Myofunctional therapy vs medical treatment

Snoring frequency: change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Myofunctional therapy vs medical treatment

Snoring intensity: change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 26 participants
Low

Myofunctional therapy vs sham

Reduction of apnoea episodes (apnoea-hypopnoea index) · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 82 participants
Low

Myofunctional therapy vs sham

Snoring frequency: change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
Very low

Myofunctional therapy vs sham

Snoring intensity: endpoint score. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 51 participants
Moderate

Myofunctional therapy vs waiting list control

Daytime sleepiness (ESS): change from baseline. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Low

Myofunctional therapy vs waiting list control

Quality of sleep · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Low

Myofunctional therapy vs waiting list control

AHI score change. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Low

Myofunctional therapy vs continuous positive airway pressure (CPAP)

Daytime sleepiness (ESS): endpoint score. · obstructive sleep apnoea

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 54 participants
Low

Mucolytic vs placebo

Outcomes* · chronic bronchitis or COPD

The review found no eligible studies for this question.

1 finding from 1 review

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mucolytic vs placebo

Participants with no exacerbations in study period · chronic bronchitis or COPD

Mucolytic probably leads to higher participants with no exacerbations in study period compared with placebo (moderate certainty).

1 finding from 1 review

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes only
Peto OR 1.73 [1.56, 1.91]
28 studies · 6723 participants
Moderate

Mucolytic vs placebo

Days of disability per participant per month · chronic bronchitis or COPD

1 finding from 1 review

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 2259 participants
Moderate

Mucolytic vs placebo

SGRQ Total SGRQ (Total) Score. Scale from: 0 to 100. Lower score indicates better quality of life. · chronic bronchitis or COPD

1 finding from 1 review

Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease 2019 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 2721 participants
Moderate